These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 31573412)

  • 41. Rapid versus slow withdrawal of antiepileptic drugs.
    Ranganathan LN; Ramaratnam S
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005003. PubMed ID: 16625621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.
    Amass L; Ling W; Freese TE; Reiber C; Annon JJ; Cohen AJ; McCarty D; Reid MS; Brown LS; Clark C; Ziedonis DM; Krejci J; Stine S; Winhusen T; Brigham G; Babcock D; Muir JA; Buchan BJ; Horton T
    Am J Addict; 2004; 13 Suppl 1(Suppl 1):S42-66. PubMed ID: 15204675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychometric evaluation of the 10-item Short Opiate Withdrawal Scale-Gossop (SOWS-Gossop) in patients undergoing opioid detoxification.
    Vernon MK; Reinders S; Mannix S; Gullo K; Gorodetzky CW; Clinch T
    Addict Behav; 2016 Sep; 60():109-16. PubMed ID: 27124502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic use of tramadol after acute pain episode: cohort study.
    Thiels CA; Habermann EB; Hooten WM; Jeffery MM
    BMJ; 2019 May; 365():l1849. PubMed ID: 31088782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in Singapore.
    Guo S; Manning V; Yang Y; Koh PK; Chan E; de Souza NN; Assam PN; Sultana R; Wijesinghe R; Pangjaya J; Kandasami G; Cheok C; Lee KM; Wong KE
    J Subst Abuse Treat; 2018 Aug; 91():1-11. PubMed ID: 29910009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical assessment of physical dependence potential of dihydroetorphine hydrochloride (DHE)].
    Ge Y; Li M; Sun WL; Cai ZJ
    Yao Xue Xue Bao; 1994; 29(4):256-60. PubMed ID: 7976340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abrupt versus gradual cessation of steroids in patients with septic shock.
    Sobolewski KA; Brophy A; Opsha Y; Zaid A; Mistry N
    J Crit Care; 2018 Dec; 48():198-202. PubMed ID: 30232056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home.
    Johnson PN; Harrison DL; Castro CH; Miller JL
    Res Social Adm Pharm; 2012; 8(5):455-63. PubMed ID: 22222345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methadone detoxification of tramadol dependence.
    Leo RJ; Narendran R; DeGuiseppe B
    J Subst Abuse Treat; 2000 Oct; 19(3):297-9. PubMed ID: 11027901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effectiveness and tolerance of tramadol in cancer pain. A comparative study with respect to buprenorphine].
    Bono AV; Cuffari S
    Drugs; 1997; 53 Suppl 2():40-9. PubMed ID: 9190324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pain after tonsillectomy: effectiveness of current guidelines?
    Walrave Y; Maschi C; Bailleux S; Falk AT; Hayem C; Carles M; De la Brière F
    Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):281-286. PubMed ID: 29080148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term evaluation of opioid treatment in fibromyalgia.
    Peng X; Robinson RL; Mease P; Kroenke K; Williams DA; Chen Y; Faries D; Wohlreich M; McCarberg B; Hann D
    Clin J Pain; 2015 Jan; 31(1):7-13. PubMed ID: 24480913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opioid interruptions, pain, and withdrawal symptoms in nursing home residents.
    Redding SE; Liu S; Hung WW; Boockvar KS
    Clin Ther; 2014 Nov; 36(11):1555-63. PubMed ID: 25455930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation.
    Collins ED; Horton T; Reinke K; Amass L; Nunes EV
    J Subst Abuse Treat; 2007 Mar; 32(2):167-75. PubMed ID: 17306725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychosocial interventions for benzodiazepine harmful use, abuse or dependence.
    Darker CD; Sweeney BP; Barry JM; Farrell MF; Donnelly-Swift E
    Cochrane Database Syst Rev; 2015; 2015(5):CD009652. PubMed ID: 26106751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heroin detoxification with buprenorphine on an inpatient psychiatric unit.
    DiPaula BA; Schwartz R; Montoya ID; Barrett D; Tang C
    J Subst Abuse Treat; 2002 Oct; 23(3):163-9. PubMed ID: 12392802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of buspirone in the treatment of opioid withdrawal.
    Buydens-Branchey L; Branchey M; Reel-Brander C
    J Clin Psychopharmacol; 2005 Jun; 25(3):230-6. PubMed ID: 15876901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lofexidine for acute opioid withdrawal: A clinical case series.
    Renfro ML; Loera LJ; Tirado CF; Hill LG
    Ment Health Clin; 2020 Sep; 10(5):259-263. PubMed ID: 33062550
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.